Israeli - Kiingereza - Ministry of Health

inovamed pharma ltd, israel - ticagrelor - film coated tablets - ticagrelor 60 mg - ticagrelor - ticagrelor inovamed , co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (acs) or- a history of myocardial infarction (mi) and a high risk of developing an atherothrombotic event. limitations of use: 90 mg twice daily during the first year after an acs event followed by 60 mg twice daily for additional 2 years.

Israeli - Kiingereza - Ministry of Health

inovamed pharma ltd, israel - ticagrelor - film coated tablets - ticagrelor 90 mg - ticagrelor - ticagrelor inovamed , co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (acs) or- a history of myocardial infarction (mi) and a high risk of developing an atherothrombotic event. limitations of use: 90 mg twice daily during the first year after an acs event followed by 60 mg twice daily for additional 2 years.

Israeli - Kiingereza - Ministry of Health

inovamed ltd - posaconazole - tablets delayed release - posaconazole 100 mg - posaconazole - posaconazole inovamed delayed-release tablets are indicated for use in the treatment of the following fungal infections in adults:- invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products;- fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b;- chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole;- coccidioidomycosis in patients with disease that is refractory to amphotericin b, itraconazole or fluconazole or in patients who are intolerant of these medicinal products.- zygomycosis in patients intolerant of or with disease that is refractory to alternative therapy.refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective antifungal therapy.noxafil gastro-resistant tablets are also indicated for prophylaxis of invasive fungal infections in the following patients:- patients receiving remission-induction chemotherapy for acute myelogenous leukemia (aml) or myelodysplastic syndromes (mds) expected to result in prolonged neutropenia and who are at high risk of developing invasive fungal infections;- hematopoietic stem cell transplant (hsct) recipients who are undergoing high-dose immunosuppressive therapy for graft versus host disease and who are at high risk of developing invasive fungal infections.

Israeli - Kiingereza - Ministry of Health

inovamed pharma ltd, israel - rosuvastatin as calcium - film coated tablets - rosuvastatin as calcium 10 mg - rosuvastatin - treatment of adults with:• primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.• homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate

Israeli - Kiingereza - Ministry of Health

inovamed pharma ltd, israel - rosuvastatin as calcium - film coated tablets - rosuvastatin as calcium 20 mg - rosuvastatin - treatment of adults with:• primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.• homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate

Israeli - Kiingereza - Ministry of Health

inovamed pharma ltd, israel - rosuvastatin as calcium - film coated tablets - rosuvastatin as calcium 40 mg - rosuvastatin - treatment of adults with:• primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.• homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate

Israeli - Kiingereza - Ministry of Health

inovamed pharma ltd, israel - rosuvastatin as calcium - film coated tablets - rosuvastatin as calcium 5 mg - rosuvastatin - treatment of adults with:• primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate.• homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate

Israeli - Kiingereza - Ministry of Health

inovamed pharma ltd, israel - pirfenidone - film coated tablets - pirfenidone 267 mg - pirfenidone - pirfenidone inovamed is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Israeli - Kiingereza - Ministry of Health

inovamed pharma ltd, israel - pirfenidone - film coated tablets - pirfenidone 801 mg - pirfenidone - pirfenidone inovamed is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Israeli - Kiingereza - Ministry of Health

inovamed ltd - finasteride - film coated tablets - finasteride - for the treatment and control of benign prostatic hyperplasia (bph) and for the prevention of urologic events to reduce the risk of acute urinary retention.reduce the risk of surgery including transurethral resection of the prostate (turp) and prostatectomy. this product causes regression of the enlarged prostate, improves urinary flow and improves the symptoms assocciated with bph. patients with an enlarged prostate are the appropriate candidates for therapy with this product.